Monica Adrian Skordilis, MD in Estacada, OR - Medicare Neurology

Monica Adrian Skordilis, MD is a medicare enrolled "Psychiatry & Neurology - Neurology" physician in Estacada, Oregon. She went to Ohio State University College Of Medicine and graduated in 2011 and has 13 years of diverse experience with area of expertise as Neurology. She is a member of the group practice Kaiser Foundation Health Plan Of The Northwest and her current practice location is 535 Ne 6th Ave, Estacada, Oregon. You can reach out to her office (for appointments etc.) via phone at (503) 630-8550.

Monica Adrian Skordilis is licensed to practice in California (license number A135546) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1184913782.

Contact Information

	Monica Adrian Skordilis, MD
	535 Ne 6th Ave, Estacada, OR 97023-9312
	(503) 630-8550
	Not Available

Physician's Profile

Full Name	Monica Adrian Skordilis
Gender	Female
Speciality	Neurology
Experience	13 Years
Location	535 Ne 6th Ave, Estacada, Oregon
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Monica Adrian Skordilis attended and graduated from Ohio State University College Of Medicine in 2011

NPI Data:

NPI Number: 1184913782
Provider Enumeration Date: 04/04/2011
Last Update Date: 08/23/2022

Medicare PECOS Information:

PECOS PAC ID: 8729399639
Enrollment ID: I20170905003135

Medical Identifiers

Medical identifiers for Monica Adrian Skordilis such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1184913782	NPI	-	NPPES
500733577	Medicaid	OR

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084N0400X	Psychiatry & Neurology - Neurology	A135546 (California)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Kaiser Foundation Health Plan Of The Northwest	5799688230	1482

News Archive

Endo Pharmaceuticals licenses investigational drug axomadol from Grunenthal

Endo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.

Igenica Biotherapeutics doses first patient in Phase 1 clinical trial of IGN523 in patients with AML

Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that the first patient has been dosed in a Phase 1 clinical trial of IGN523 in patients with relapsed or refractory acute myeloid leukemia (AML).

Hereditary genes responsible for pain severity after motor vehicle collisions

Two studies presented at the ANESTHESIOLOGY 2012 annual meeting found that hereditary genes were responsible for the amount and type of pain experienced after a motor vehicle collision (MVC).

UF awarded $1.2M grant to support UF-HHMI Science for Life Program

Imagine a chemistry professor and a neuroscientist working together to test a new drug to fight Alzheimer's disease, or a biomedical engineer working with an orthopedic surgeon to help patients walk again.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Monica Adrian Skordilis allows following entities to bill medicare on her behalf.

Entity Name	Kaiser Foundation Health Plan Of The Northwest
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799

News Archive

Endo Pharmaceuticals licenses investigational drug axomadol from Grunenthal

Endo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.

Igenica Biotherapeutics doses first patient in Phase 1 clinical trial of IGN523 in patients with AML

Hereditary genes responsible for pain severity after motor vehicle collisions

Two studies presented at the ANESTHESIOLOGY 2012 annual meeting found that hereditary genes were responsible for the amount and type of pain experienced after a motor vehicle collision (MVC).

UF awarded $1.2M grant to support UF-HHMI Science for Life Program

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Monica Adrian Skordilis is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Monica Adrian Skordilis, MD Po Box 546, Gresham, OR 97030-0132 Ph: () -	Monica Adrian Skordilis, MD 535 Ne 6th Ave, Estacada, OR 97023-9312 Ph: (503) 630-8550

News Archive

Endo Pharmaceuticals licenses investigational drug axomadol from Grunenthal

Endo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.

Igenica Biotherapeutics doses first patient in Phase 1 clinical trial of IGN523 in patients with AML

Hereditary genes responsible for pain severity after motor vehicle collisions

Two studies presented at the ANESTHESIOLOGY 2012 annual meeting found that hereditary genes were responsible for the amount and type of pain experienced after a motor vehicle collision (MVC).

Monica Adrian Skordilis, MD - Medicare Neurology in Estacada, OR

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Endo Pharmaceuticals licenses investigational drug axomadol from Grunenthal

Igenica Biotherapeutics doses first patient in Phase 1 clinical trial of IGN523 in patients with AML

Hereditary genes responsible for pain severity after motor vehicle collisions

UF awarded $1.2M grant to support UF-HHMI Science for Life Program

Medicare Reassignments

Endo Pharmaceuticals licenses investigational drug axomadol from Grunenthal

Igenica Biotherapeutics doses first patient in Phase 1 clinical trial of IGN523 in patients with AML

Hereditary genes responsible for pain severity after motor vehicle collisions

UF awarded $1.2M grant to support UF-HHMI Science for Life Program

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Endo Pharmaceuticals licenses investigational drug axomadol from Grunenthal

Igenica Biotherapeutics doses first patient in Phase 1 clinical trial of IGN523 in patients with AML

Hereditary genes responsible for pain severity after motor vehicle collisions

UF awarded $1.2M grant to support UF-HHMI Science for Life Program

Psychiatry & Neurology Doctors in Estacada, OR